Shan Lv

1.3k total citations
46 papers, 891 citations indexed

About

Shan Lv is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shan Lv has authored 46 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 16 papers in Molecular Biology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shan Lv's work include Adipose Tissue and Metabolism (13 papers), Nutrition and Health in Aging (8 papers) and Hormonal Regulation and Hypertension (6 papers). Shan Lv is often cited by papers focused on Adipose Tissue and Metabolism (13 papers), Nutrition and Health in Aging (8 papers) and Hormonal Regulation and Hypertension (6 papers). Shan Lv collaborates with scholars based in China, United States and Australia. Shan Lv's co-authors include Jing Yu, Wenqing Xie, Wenjuan Di, Hanmei Qi, Miao He, Wenfeng Xiao, Yunlu Sheng, Yuxiang Wu, Guoxian Ding and Dengjie Yu and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Shan Lv

45 papers receiving 884 citations

Peers

Shan Lv
Shan Lv
Citations per year, relative to Shan Lv Shan Lv (= 1×) peers Simona Giovagnetti

Countries citing papers authored by Shan Lv

Since Specialization
Citations

This map shows the geographic impact of Shan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lv more than expected).

Fields of papers citing papers by Shan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lv. The network helps show where Shan Lv may publish in the future.

Co-authorship network of co-authors of Shan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Lv. A scholar is included among the top collaborators of Shan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Lv. Shan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shiying, Mengyun Zou, Yingjie Wang, et al.. (2025). Matrix metalloproteinase 7 (MMP7) as a molecular target for Mycoplasma gallisepticum (MG) resistance in chickens. International Journal of Biological Macromolecules. 298. 140110–140110. 4 indexed citations
2.
Wang, Yingjie, Shiying Li, Shan Lv, et al.. (2025). Enhancer of Zeste homolog 2–mediated histone H3 lysine 27 trimethylation silences LIM domain-containing protein 1 and activates hippo signaling in Mycoplasma pathogenesis. International Journal of Biological Macromolecules. 332(Pt 2). 148731–148731. 1 indexed citations
3.
Wang, Chong, Shan Lv, András Dinnyés, et al.. (2024). Exploring the key deteriorative microorganisms on ancient ivories unearthed from the Sanxingdui Ruins site during temporary cold storage. Frontiers in Microbiology. 15. 1400157–1400157. 4 indexed citations
4.
Lv, Shan, et al.. (2024). Elucidating VSMC phenotypic transition mechanisms to bridge insights into cardiovascular disease implications. Frontiers in Cardiovascular Medicine. 11. 1400780–1400780. 8 indexed citations
5.
Lv, Shan, Hongfei Tai, Jun Sun, et al.. (2024). Mapping macrostructural and microstructural brain alterations in patients with neuronal intranuclear inclusion disease. Neuroradiology. 66(8). 1373–1382.
6.
Wang, Tengfei, Wenqing Zhao, Shan Lv, et al.. (2024). Unmasking the dynamics of Mycoplasma gallisepticum: deciphering HD11 macrophage polarization for innovative infection control strategies. Poultry Science. 103(5). 103652–103652. 1 indexed citations
7.
Li, Hanwen, Sihan Hu, Kai Zhang, et al.. (2023). 11β-Hydroxysteroid Dehydrogenase Type 1 Facilitates Osteoporosis by Turning on Osteoclastogenesis through Hippo Signaling. International Journal of Biological Sciences. 19(11). 3628–3639. 12 indexed citations
8.
Lv, Shan, Hengzhen Li, Qun Chen, et al.. (2023). Caloric restriction delays age-related muscle atrophy by inhibiting 11β−HSD1 to promote the differentiation of muscle stem cells. Frontiers in Medicine. 9. 1027055–1027055. 2 indexed citations
9.
Lobo, Neil F., Florence Fouque, Chen Gao, et al.. (2023). Challenge and opportunity for vector control strategies on key mosquito-borne diseases during the COVID-19 pandemic. Frontiers in Public Health. 11. 1207293–1207293. 12 indexed citations
10.
Yao, Pu, Qianmei Wang, Qing Dai, et al.. (2023). Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy. Pharmaceutics. 15(7). 1827–1827. 12 indexed citations
11.
Wang, Tengfei, Shan Lv, Yufei Xiao, et al.. (2023). Avian safety guardian: Luteolin restores Mycoplasma gallisepticum-induced immunocompromise to improve production performance via inhibiting the IL-17/NF-kB pathway. International Immunopharmacology. 124(Pt B). 110946–110946. 7 indexed citations
12.
Tai, Hongfei, Zaiqiang Zhang, Yunyun Duan, et al.. (2022). Characteristic cerebral perfusion pattern in neuronal intranuclear inclusion disease. Frontiers in Neuroscience. 16. 1081383–1081383. 1 indexed citations
13.
Chen, Lei, Yunlu Sheng, Hanmei Qi, et al.. (2020). Correlation of sarcopenia and depressive mood in older community dwellers: a cross-sectional observational study in China. BMJ Open. 10(9). e038089–e038089. 29 indexed citations
14.
Tang, Tingting, Juan Liu, Jing Yu, et al.. (2020). Low muscle mass impairs fat utilization during light-intensity exercise in Chinese men. Annals of Palliative Medicine. 9(4). 1453–1461. 2 indexed citations
15.
Xie, Wenqing, Gelei Xiao, Yibin Fan, et al.. (2019). Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria. Aging Clinical and Experimental Research. 33(2). 247–252. 61 indexed citations
16.
Liu, Juan, et al.. (2018). Targeted Molecular Magnetic Resonance Imaging Detects Brown Adipose Tissue with Ultrasmall Superparamagnetic Iron Oxide. BioMed Research International. 2018. 1–8. 4 indexed citations
17.
Huang, Min, Juan Liu, Yunlu Sheng, et al.. (2018). 11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy. Journal of Molecular and Cellular Cardiology. 125. 106–116. 10 indexed citations
18.
Liu, Juan, Long Wang, Aisen Zhang, et al.. (2011). Adipose tissue-targeted 11.BETA.-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity. Endocrine Journal. 58(3). 199–209. 21 indexed citations
19.
Lv, Shan, Cheng Peng, Aisen Zhang, et al.. (2010). Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation. Experimental and Therapeutic Medicine. 1(4). 603–610. 18 indexed citations
20.
Sun, Leping, et al.. (2009). Application and perspective of climatic forecasting models related to schistosomiasis transmission.. 21(5). 432–436. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026